Pregnancy is accompanied by changes in thyroid function, but limited data are available on these changes in the very first weeks of pregnancy. Yet, T 4 plays a major role in implantation and early fetal development. We sought to determine thyroid function during this period and during the first trimester, in pregnancies achieved by assisted reproductive technology. Furthermore, the thyroid hormone profile was compared between euthyroid women with (TAI؉) and without (TAI؊) thyroid autoimmunity. We prospectively analyzed data from 35 women who received ovarian hyperstimulation (OH) and presented clinical pregnancies. The mean age of the women was 32 ؎ 5 yr. Thyroid function tests [serum TSH and free T 4 (FT 4 )] and thyroid antibody status were determined before OH (baseline values) and every 20 d after ovulation induction during the first trimester of pregnancy. Serum TSH and FT 4 increased significantly at d 20, compared with baseline values (3.3 ؎ 2.4 vs. 1.8 ؎ 0.9 mU/liter; P < 0.0001 and 13.2 ؎ 1.7 vs. 12.4 ؎ 1.9 ng/liter; P ‫؍‬ 0.005). During the first trimester of pregnancy, there was a significant change over time for TSH and FT 4 (P < 0.001 and P ‫؍‬ 0.005, respectively). Nine women (27%) were TAI؉. The TSH curve among these TAI؉ women was significantly higher compared with TAI؊ women (P ‫؍‬ 0.010). The opposite was observed for the FT 4 curve (P ‫؍‬ 0.020).
T HYROID DISORDERS INTERFERE with several aspects
of reproduction (1, 2) . Euthyroid women with thyroid autoimmunity (TAIϩ) have an increased risk for miscarriage, and the prevalence of TAIϩ is increased in women with female causes of infertility (i.e. endometriosis, tubal disease, and ovulatory dysfunction) (3) (4) (5) . The pathophysiology underlying the association between TAI and miscarriage remains to be elucidated. Three major possibilities for the observed association can be considered: first an immune dysfunction (although yet to be defined) can be involved. Second a direct action of antithyroglobulin antibodies (TgAb) on the placenta has been described in mice; to date this has not been described in humans (6) . Third, a possible decrease of local thyroid hormones in the presence of TAI during pregnancy can play a role in miscarriage (7) .
During pregnancy, the thyroid is submitted to stressors and undergoes several adaptations to maintain sufficient output of thyroid hormones for both the mother and fetus. Changes known to affect thyroid function during gestation are the human chorionic gonadotropin (hCG) peak values (8th-10th weeks), the increased estrogen levels inducing a progressive increase in serum thyroxine-binding globulin (TBG) concentrations, followed in turn by a reduction in free T 4 (FT 4 ) and a compensatory increase in serum TSH. However, both serum TSH and FT 4 remain within normal reference ranges, unless pregnancy is associated with iodine deficiency (8 -10) . Ovarian hyperstimulation (OH) used in preparation of assisted reproductive technology (ART) has been shown to impair thyroid function (11) . Moreover, in euthyroid pregnant women with positive thyroid antibodies, it has been shown that 16% had increased serum TSH at delivery (12) .
By measuring TSH and FT 4 before ART and subsequently every 20 d after ovulation induction (OI; or the end of OH, considered as time 0) during the first trimester of pregnancy, our aim was to investigate changes in thyroid function occurring in the very early phases of pregnancy, i.e. before the impact of high hCG levels. A further aim was to assess the TSH and FT 4 changes over time during the first trimester of pregnancy and to explore the potential impact of TAIϩ on thyroid function.
Patients and Methods

Overall study design
Women of infertile couples presenting at the Centre of Reproductive Medicine (Brussels, Belgium) were included prospectively after inAbbreviations: ART, Assisted reproductive technology; FT 4 , free T 4 ; hCG, human chorionic gonadotropin; OH, ovarian hyperstimulation; OI, ovulation induction; TAI, thyroid autoimmunity; TBG, thyroxinebinding globulin; Tg-Ab, antithyroglobulin antibodies; TPO-Ab, thyroid peroxidase antibodies.
formed consent. Causes of infertility among women studied were as follows: male infertility (57%), tubal diseases (17%), endometriosis (14%), ovulatory disorders (6%), and idiopathic cause (6%).
Only euthyroid women, with an ongoing pregnancy after having received OH, were included in the study; no particular thyroid characteristic that might have influenced the success of ART was evidenced in the present cohort.
Thyroid function tests (serum TSH and FT 4 ) and thyroid peroxidase antibodies (TPO-Ab) were determined before (Ն20 d) a first ART procedure, and thyroid function was further monitored every 20 d after OI during the first trimester of pregnancy. The end of OH was considered as time 0 (or OI). To evaluate thyroid function in the earliest stages of the first trimester (i.e. before the impact of high hCG levels), thyroid function tests obtained 20 d after OI were compared with pre-OH values. The pattern of change of thyroid function during the first trimester was further determined by measuring TSH and FT 4 at d 20, 40, 60, 80, and 100 after successful OH. To assess the potential impact of TAI on thyroid function, women were stratified according to the presence or absence of TAI.
ART treatment
All female partners received controlled ovarian superovulation treatment by a combination of the GnRH agonist (Suprefact nasal spray, Aventis, Strasbourg, France) and uFSH (Menopur; Ferring Pharmaceuticals, Copenhagen, Denmark) or recFSH (Puregon, Organon International Inc., West Orange, NJ; and Gonal-F; Serono, Geneva, Switzerland). When the patient had at least three follicles with a diameter of 17 mm and serum estradiol levels of 1000 ng/liter, administration of both GnRH agonist and FSH were discontinued, and ovulation was induced with 10,000 IU of hCG (Pregnyl; Organon).
All patients had a transvaginal ultrasound-guided ovum aspiration approximately 36 h after hCG injection under local anesthesia.
In conventional in vitro fertilization, each oocyte was inseminated within 3-4 h after retrieval by adding 5,000 -20,000 motile spermatozoa per oocyte. For intracytoplasmic sperm injection, only mature metaphase II oocytes were injected after denuding their cumulus cells. The intracytoplasmic sperm injection procedure was carried out as described earlier (13) . After fertilization, one to three embryos were transferred depending on their morphological quality. The luteal phase was supplemented by vaginal administration of 3 ϫ 600 mg natural micronized progesterone (Utrogestan; Besins, Brussels, Belgium) starting 1 d after oocyte retrieval.
Pregnancy was diagnosed at least 10 d after transfer by rising hCG levels of at least 20 IU/ml in serum on two occasions. Clinical pregnancies were diagnosed by ultrasonography performed 5 weeks after embryo transfer.
Serum assay
Serum TSH and FT 4 were measured using a third-generation electrochemiluminescence immunoassay (Roche, Mannheim, Germany). The reference values were 0.27-4.2 mU/liter for TSH and 9.3-18.0 ng/liter (12-23.2 pmol/liter) for FT 4 [conversion factor for FT 4 (nanograms per liter 3 picomoles per liter), 1.29]. Thyroid autoimmunity was demonstrated by the presence of TPO-Ab (positive when Ͼ100 kU/liter or TAIϩ). TPO-Ab was determined using a RIA kit (B.R.A.H.M.S. Diagnostica, Berlin). The reference range was 0 -100 kU/liter.
Tg-Ab were not measured because our preliminary unpublished data showed that Tg-Ab, in the absence of TPO-Ab, were observed in less than 5% of TAI women.
Statistical analysis
Serum TSH and FT 4 values, in this cohort of infertile women, passed the Kolmogoroff-Smirnoff test for normal distribution and were therefore expressed as mean Ϯ sd. To compare changes between pre-and post-OH values of TSH and FT 4 in the early stage of pregnancy (i.e. between baseline values and values at d 20 after successful OH), the paired Student's t test was used. The unpaired Student's t test was used to compare differences in thyroid function between TAIϩ and TAIϪ patients at baseline and at d 20. A one-way (single group) repeatedmeasures ANOVA was conducted to explore the impact of time on TSH and FT 4 serum values collected at six periods: before OH (time 0), and at d 20, 40, 60, 80, and 100 after OI. A two-way (between groups) repeated-measures ANOVA was conducted to explore the impact of thyroid antibodies on thyroid function, as measured by serum TSH and FT 4 values during the first trimester of pregnancy. TPO-Ab titers were not normally distributed and were expressed as the median value (and the range). Titers were compared between TAIϩ and TAIϪ patients by a Mann-Whitney U test. All data analyses were performed using SPSS version 11.5 (SPSS, Inc., Chicago, IL). Table 1 shows the clinical and biochemical characteristics of all women enrolled (n ϭ 35) and stratified according to the presence (TAIϩ group, n ϭ 9) or absence of thyroid autoimmunity (TAIϪ group, n ϭ 27). In the entire study group, the women's mean age was 32 Ϯ 5 yr (range, 23-40 yr), and their mean serum TSH and FT 4 at baseline were 1.8 Ϯ 0.9 mU/liter and 12.4 Ϯ 1.9 ng/liter, respectively. There were no significant differences between the TAIϩ group and the TAIϪ group with regard to mean age, mean serum TSH, mean serum FT 4 , and mean serum hCG levels at the different time points. Individual titers of TPO antibodies, in the nine TAIϩ patients, ranged between 132, 165, 179, 279, 364, 1221, 2155, 3753, and 3666 kU/liter. Figure 1 shows changes in thyroid function occurring in the very early phases of pregnancy, i.e. before the impact of high hCG levels.
Results
Baseline characteristics
Thyroid function in the very early phases of pregnancy
In the entire study group, serum TSH increased signifi- Fig.  1 , left panels). When stratified according to the presence (TAIϩ group) or absence (TAIϪ group) of thyroid autoimmunity, similar trends were observed, although with the numbers available, these trends did not always reach statistical significance (Fig. 1, right panels) . Figure 2 shows the pattern of changes in serum TSH and FT 4 during the first trimester of pregnancy in the entire study group (Fig. 2, left panels) and after stratification according to the presence (TAIϩ group) or absence (TAIϪ group) of thyroid autoimmunity (Fig. 2, right panels) . In the entire study group, there was a statistically significant effect for time on TSH and on FT 4 (one-way repeated-measures ANOVA for TSH and FT 4 , P Ͻ 0.001 and P ϭ 0.005, respectively). The peak values for TSH and for FT 4 occurred at d 20 and 40, respectively. When stratified according to TAI status, there was a statistically significant effect, both for serum TSH and FT 4 . For serum TSH, the curve was significantly higher among TAIϩ women (two-way repeated-measures ANOVA for TSH, P ϭ 0.010). Conversely, for serum FT 4 , the curve was significantly lower among TAIϩ women (two-way repeatedmeasures ANOVA for FT 4 , P ϭ 0.020).
Thyroid function during the first trimester of pregnancy
The outcome of induced pregnancies, as of the end of the study period (first trimester), showed a miscarriage rate of 56 and 39%, respectively, among the TAIϩ vs. TAIϪ groups. These percentages were not statistically different between the groups, due to the small number of patients. Thyroid hormone levels were not statistically different between those (last available) in the miscarriage group and the ongoing group. Mean (Ϯsd) serum TSH levels at time point 80 d was 3.3 Ϯ 2.2 mU/liter in the miscarriage group vs. 2.0 Ϯ 1.3 mU/liter in the ongoing pregnancy group (P ϭ 0.116). FT 4 levels were, respectively, 12.5 Ϯ 1.7 and 13.4 Ϯ 1.5 ng/liter (P ϭ 0.223). At the time point 100 d, serum TSH was 2.9 Ϯ 2.1 mU/liter in the miscarriage group and 2.2 Ϯ 1.5 mU/liter in the ongoing pregnancies group (P ϭ 0.422).
FT 4 levels were 11.9 Ϯ 1.3 and 12.5 Ϯ 1.6 ng/liter, respectively, in the miscarriage and ongoing pregnancy groups (P ϭ 0.509).
Discussion
The present prospective study presented a unique opportunity to study the very early changes in thyroid function during the first trimester of pregnancy after ART and especially during the first month, when hCG levels were still too low (Ͻ1000 IU/liter) to directly influence thyroid function. We observed a significant increase in serum TSH and FT 4 levels compared with baseline values. Previously, only Muller et al. (11) investigated thyroid function after OH. These authors measured thyroid function tests in the immediate period after OH but did not precisely specify the timing in relation to the OI, nor did they precisely specify the outcome (pregnancy status) of the patients included. Interestingly, they found a significant increase in serum TSH and a decrease in FT 4 levels compared with pre-OH levels. The postulated mechanism whereby OH leads to these changes in thyroid tests is by inducing a rapid increase in the estrogen levels and in turn TBG production and hypersialylation, with the latter increasing TBG's half-life. The increase in TBG results in an increase in total T 4 that tends to lower serum FT 4 , thereby stimulating serum TSH through the pituitary-thyroid feedback mechanisms (8) . In line with those results, we found significantly increased values for TSH levels at 20 d after OI compared with baseline values. By contrast, in the present study, we found significantly increased values for both TSH and FT 4 serum levels at 20 d after OI (compared with baseline values). The increase in serum TSH might be related to the high estrogen levels resulting from FSHinduced OH, whereas the injection of hCG for the induction of ovulation might have counteracted the lowering in serum FT 4 levels by directly stimulating the thyroid gland (14) . A central mechanism to explain these changes in the thyroid hormonal profile is unlikely, because evidence for a direct stimulating effect of estrogen and hCG is lacking at the hypothalamo-pituitary level. The changes in both serum TSH and FT 4 during the first trimester were comparable with the thyroid function patterns observed in spontaneous pregnancies. After the early peak value in serum TSH, a decrease in TSH and a further slightly delayed peak value in FT 4 are subsequently mediated through rising hCG levels.
A further aim of the study was to assess whether the evolution of thyroid function was similar in women with/ without TAI. In a previous case-control study of women from infertile couples, we found an impact of TAIϩ on thyroid function, and a clear statistically significant correlation was established between TPO-Ab titers and serum TSH levels before OH. In that study, we also showed that women with a female cause of infertility had an increased risk of being TAIϩ, compared with fertile controls (5) . In a subsequent prospective cohort study of infertile women with TAIϩ submitted to OH, we found an increased risk for miscarriage during the first trimester, compared with TAIϪ women (4).
A similar tendency was found in the present study; namely an increased miscarriage rate in the TAIϩ compared with the TAIϪ group. However, the difference was not statistically different because of the small number of patients investigated. The reasons for such an association remain to be elucidated. Although the hypothesis of a generalized deregulation of immunity is plausible, the development of a relative thyroid dysfunction in women with TAIϩ during pregnancy is possible (12) . The present study confirmed that there was a difference in the dynamics of thyroid function changes between TAIϩ and TAIϪ women, based on the significantly different serum levels for TSH and FT 4 collected at several time periods during the first trimester of pregnancy. The increase in serum TSH was more pronounced, whereas the serum FT 4 response was attenuated in TAIϩ patients. These results point to a diminished thyroid functional reserve during the ART procedure and subsequent early pregnancy in this subset of patients. Thus, both OH and TAI are factors that can attenuate the normal thyroid response needed for maintaining an ongoing pregnancy after OH. We also should be aware that reference values for thyroid function are normal values during nonpregnant states and that they may be inappropriate for a certain time point of pregnancy. In the present study, we did not find differences in the thyroid hormone levels between the miscarriage and ongoing group; however, a larger number of patients should be investigated to be conclusive on this issue. To date, one study investigated the impact of thyroid hormones on the outcome of spontaneous pregnancy in TAIϩ women. In that small (n ϭ 16) nonplacebo controlled study, only women with a history of recurrent miscarriage were included. Thyroid hormones before and during pregnancy yielded a significantly better outcome than treatment with Igs during gestation (15) .
Clearly, prospective randomized studies comparing the outcome of pregnancy in euthyroid TAIϩ women treated by T 4 or placebo are needed to answer the remaining question of whether the impaired pregnancy in those patients can be reversed. Previous studies associating TAIϩ and thyroid dysfunction with infertility, miscarriage, postpartum thyroiditis, depression, and minor thyroid dysfunction with impaired neuro-intellectual outcome in children (2, 5, 16 -19) , together with the present study, provide strong evidence to propose systematic screening of infertile women for TSH, FT 4 , and TPO-Ab before an ART procedure. We also recommend surveillance of thyroid function during subsequent pregnancy in the TAIϩ women.
In conclusion, the present study showed a significant increase in serum TSH and FT 4 levels after OH in the very first period of pregnancy compared with pre-OH levels and a significant impact of TAI on thyroid function during the first trimester, providing evidence for an altered thyroid function in TAIϩ patients.
These changes may be markers of the underlying thyroid alterations possibly associated with the increased miscarriage risk.
